Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Leval

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
European Urology|December 26, 2001
Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomyD Waltregny, L de Leval, L Coppens, et al.
Revue Medicale De Liege|May 15, 1986
[Treatment of cancer of the prostate with Zoladex Depot]C Bouffioux, C Focan, J Désirotte, et al.
European Urology|January 1, 1992
Original lithotomy positioning for transperineal extracorporeal shockwave lithotripsy for distal ureteric calculi with Tripter X1R Andrianne, C Vandeberg, P Bonnet, et al.
Acta Urologica Belgica|December 1, 1994
The experience of the CHU Liège with conservative surgery in the management of upper urinary tract tumorsC Bouffioux, R Andrianne, P Bonnet, et al.
Molecular and Cellular Endocrinology|October 1, 1992
Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature ratsE Reiter, P Bonnet, B Sente, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 10, 2001
PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinomaP Nickers, L Coppens, M Beauduin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levelsP Bonnet, E Reiter, M Bruyninx, et al.
The American Journal of Pathology|November 5, 1997
Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomasP Dehan, D Waltregny, A Beschin, et al.
Revue Medicale De Liege|February 10, 2000
[Surgery, radiotherapy or hormonal therapy in the treatment of prostate cancer]P Bonnet, L Coppens, R Andrianne, et al.
Journal of the National Cancer Institute|July 17, 1998
Prognostic value of bone sialoprotein expression in clinically localized human prostate cancerD Waltregny, A Bellahcène, I Van Riet, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
European Urology|December 26, 2001
Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomyD Waltregny, L de Leval, L Coppens, et al.
Revue Medicale De Liege|May 15, 1986
[Treatment of cancer of the prostate with Zoladex Depot]C Bouffioux, C Focan, J Désirotte, et al.
European Urology|January 1, 1992
Original lithotomy positioning for transperineal extracorporeal shockwave lithotripsy for distal ureteric calculi with Tripter X1R Andrianne, C Vandeberg, P Bonnet, et al.
Acta Urologica Belgica|December 1, 1994
The experience of the CHU Liège with conservative surgery in the management of upper urinary tract tumorsC Bouffioux, R Andrianne, P Bonnet, et al.
Molecular and Cellular Endocrinology|October 1, 1992
Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature ratsE Reiter, P Bonnet, B Sente, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 10, 2001
PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinomaP Nickers, L Coppens, M Beauduin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levelsP Bonnet, E Reiter, M Bruyninx, et al.
The American Journal of Pathology|November 5, 1997
Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomasP Dehan, D Waltregny, A Beschin, et al.
Revue Medicale De Liege|February 10, 2000
[Surgery, radiotherapy or hormonal therapy in the treatment of prostate cancer]P Bonnet, L Coppens, R Andrianne, et al.
Journal of the National Cancer Institute|July 17, 1998
Prognostic value of bone sialoprotein expression in clinically localized human prostate cancerD Waltregny, A Bellahcène, I Van Riet, et al.
Pageof 12